Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinicoeconomics and Outcomes Research : CEOR|September 18, 2023
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain AmyloidosisMorie Gertz, Rafat Abonour, Sarah N Gibbs, et al.
Circulation. Heart Failure|September 5, 2019
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac AmyloidosisMathew S Maurer, Sabahat Bokhari, Thibaud Damy, et al.
JACC. Cardiovascular Imaging|June 4, 2025
Global Practices in Cardiac Imaging for Cardiac Sarcoidosis: A Survey Study of International Experts With Delphi ConsensusTahir S Kafil, Manuel L Ribeiro Neto, Marc A Judson, et al.
JACC. Cardiooncology|November 29, 2022
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA TrialMonique C Minnema, Angela Dispenzieri, Giampaolo Merlini, et al.
Stem Cell Research|July 8, 2026
Generation of three induced pluripotent stem cell lines from an immune checkpoint inhibitor-induced myocarditis patient and controlsYin Sun, Maria Rosaria Vitale, Anna P Hnatiuk, et al.
JAMA Cardiology|February 23, 2022
High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep LearningGrant Duffy, Paul P Cheng, Neal Yuan, et al.
JACC. Cardiooncology|October 4, 2021
Mitochondria-Rich Extracellular Vesicles Rescue Patient-Specific Cardiomyocytes From Doxorubicin Injury: Insights Into the SENECA TrialConnor G O'Brien, Mehmet Ozgun Ozen, Gentaro Ikeda, et al.
JAMA Cardiology|November 10, 2025
Detecting Transthyretin Cardiac Amyloidosis With Artificial Intelligence: A Nonrandomized Clinical TrialSneha S Jain, Tony Sun, Emma Pierson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPYMaja Ivanovic, Antonia Chan, Evaline Cheng, et al.
Blood|March 4, 2026
Prognostic Factors and Progression Biomarkers in AL Amyloidosis: Mapping Current Knowledge and Critical GapsRajshekhar Chakraborty, Yevgeniy Brailovsky, Mazen Hanna, et al.
Pageof 5